Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pulmonx (LUNG) Gross Profit (2019 - 2025)

Pulmonx (LUNG) has disclosed Gross Profit for 7 consecutive years, with $16.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Gross Profit rose 6.83% to $16.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $67.2 million, a 14.24% increase, with the full-year FY2024 number at $62.0 million, up 22.16% from a year prior.
  • Gross Profit was $16.1 million for Q3 2025 at Pulmonx, down from $17.2 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $17.6 million in Q4 2024 to a low of $6.6 million in Q1 2021.
  • A 5-year average of $12.5 million and a median of $12.7 million in 2023 define the central range for Gross Profit.
  • Peak YoY movement for Gross Profit: soared 792.19% in 2021, then increased 4.24% in 2022.
  • Pulmonx's Gross Profit stood at $10.3 million in 2021, then rose by 9.1% to $11.2 million in 2022, then increased by 28.76% to $14.4 million in 2023, then grew by 22.15% to $17.6 million in 2024, then decreased by 8.74% to $16.1 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Gross Profit are $16.1 million (Q3 2025), $17.2 million (Q2 2025), and $16.3 million (Q1 2025).